The Association of Introducing a Faecal Calprotectin Testing Pathway for Suspected Inflammatory Bowel Disease in Primary Care and Time to Diagnosis or Treatment

by Amy Hicks, P. John Hamlin, Christian P. Selinger
Published 2020-09-01

Gastric ulcers: malignancy yield and risk stratification for follow-up endoscopy

by Christian P Selinger, Rebecca Cochrane, Sangeetha Thanaraj, Anita Sainsbury, Venkat Subramanian, Simon Everett
Published 2016-05-01

Screening for TB in Hospitalised Patients with Inflammatory Bowel Disease before Anti-TNF Therapy: Is QuantiFERON^® Gold Testing Useful?

by Jessica Lovatt, Deborah Gascoyne-Binzi, Thomas Hussey, Maya Garside, Fiona McGill, Christian P. Selinger
Published 2021-04-01

Factors affecting clinical decision-making in inflammatory bowel disease and the role of point-of-care calprotectin

by Yannick Derwa, Christopher J.M. Williams, Ruchit Sood, Saqib Mumtaz, M. Hassan Bholah, Christian P. Selinger, P. John Hamlin, Alexander C. Ford, David J. Gracie
Published 2018-01-01

Infliximab Therapeutic Drug Monitoring in Inflammatory Bowel Disease Virtual Biologics Clinic Leads to Durable Clinical Results

by Rebecca Sagar, Marco V. Lenti, Tanya Clark, Helen J. Rafferty, David J. Gracie, Alexander C. Ford, Anthony O’Connor, Tariq Ahmad, P. John Hamlin, Christian P. Selinger
Published 2021-04-01